This paper is in the following e-collection/theme issue:

Exercise and Diet Tracking for Diabetes Patients (78) Web-based and Mobile Health Interventions (3128) Innovations and Technology for Healthy Eating Education (400) Prevention and Health Promotion (899) Health Coaching for Diabetes Patients (142)

Published on in Vol 8 (2023)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/44295, first published .
Psychological Support Strategies for Adults With Type 2 Diabetes in a Very Low–Carbohydrate Web-Based Program: Randomized Controlled Trial

Psychological Support Strategies for Adults With Type 2 Diabetes in a Very Low–Carbohydrate Web-Based Program: Randomized Controlled Trial

Psychological Support Strategies for Adults With Type 2 Diabetes in a Very Low–Carbohydrate Web-Based Program: Randomized Controlled Trial

Authors of this article:

Laura R Saslow1 Author Orcid Image ;   Amanda L Missel1, 2 Author Orcid Image ;   Alison O’Brien1, 3 Author Orcid Image ;   Sarah Kim4 Author Orcid Image ;   Frederick M Hecht5 Author Orcid Image ;   Judith T Moskowitz6 Author Orcid Image ;   Hovig Bayandorian7 Author Orcid Image ;   Martha Pietrucha1 Author Orcid Image ;   Kate Raymond1 Author Orcid Image ;   Blair Richards8 Author Orcid Image ;   Bradley Liestenfeltz1 Author Orcid Image ;   Ashley E Mason5, 9 Author Orcid Image ;   Jennifer Daubenmier10 Author Orcid Image ;   James E Aikens11 Author Orcid Image
Article Authors Cited by (2) Tweetations (4) Metrics

    Original Paper

    1Department of Health Behavior and Biological Sciences, School of Nursing, University of Michigan, Ann Arbor, MI, United States

    2Department of Learning Health Sciences, University of Michigan Medical School, Ann Arbor, MI, United States

    3Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor, MI, United States

    4Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, San Francisco General Hospital, San Francisco, CA, United States

    5Osher Center for Integrative Health, University of California San Francisco, San Francisco, CA, United States

    6Feinberg School of Medicine, Northwestern University, Chicago, IL, United States

    7Michigan Institute for Clinical and Health Research, University of Michigan, Ann Arbor, MI, United States

    8Department of Psychiatry, University of California San Francisco, San Francisco, CA, United States

    9Institute of Holistic Health Studies, San Francisco State University, San Francisco, CA, United States

    10Department of Family Medicine, University of Michigan Medical School, Ann Arbor, MI, United States

    Corresponding Author:

    Laura R Saslow, PhD

    Department of Health Behavior and Biological Sciences

    School of Nursing

    University of Michigan

    Room 2178 400NIB

    Ann Arbor, MI, 48109

    United States

    Phone: 1 (734) 764 7836

    Email: saslowl@umich.edu


    Background: A very low–carbohydrate (VLC) nutritional strategy may improve glycemic control and weight loss in adults with type 2 diabetes (T2D). However, the supplementary behavioral strategies that might be able to improve outcomes using this nutritional strategy are uncertain.

    Objective: This study aims to compare the impact of adding 3 different supplementary behavioral strategies to a web-based VLC diet intervention. To our knowledge, this is the first trial to randomize participants to different frequencies of dietary self-monitoring.

    Methods: The study included 112 overweight adults with T2D (hemoglobin A1c ≥6.5%) taking no antiglycemic medications or only metformin. They received a remotely delivered 12-month VLC diet intervention. Participants were randomly assigned through a full factorial 2×2×2 design to supplementary strategies: either daily or monthly dietary self-monitoring, either mindful eating training or not, and either positive affect skills training or not. Our research goal was to determine whether 3 different supplemental strategies had at least a medium effect size (Cohen d=0.5).

    Results: Overall, the VLC intervention led to statistically significant improvements in glycemic control (−0.70%, 95% CI −1.04% to −0.35%; P<.001), weight loss (−6.82%, 95% CI −8.57% to −5.08%; P<.001), and depressive symptom severity (Cohen d −0.67, 95% CI −0.92 to −0.41; P<.001). Furthermore, 30% (25/83) of the participants taking metformin at baseline reduced or discontinued their metformin. Only 1 Cohen d point estimate reached 0.5; daily (vs monthly) dietary self-monitoring had a worse impact on depressive symptoms severity (Cohen d=0.47, 95% CI −0.02 to 0.95; P=.06). None of the strategies had a statistically significant effect on outcomes. For changes in our primary outcome, hemoglobin A1c, the daily (vs monthly) dietary self-monitoring impact was 0.42% (95% CI −0.28% to 1.12%); for mindful eating, it was −0.47% (95% CI −1.15% to 0.22%); and for positive affect, it was 0.12% (95% CI −0.57% to 0.82%). Other results for daily (vs monthly) dietary self-monitoring were mixed, suggesting an increase in weight (0.98%) and depressive symptoms (Cohen d=0.47), less intervention satisfaction (Cohen d=−0.20), more sessions viewed (3.02), and greater dietary adherence (Cohen d=0.24). For mindful eating, the results suggested a benefit for dietary adherence (Cohen d=0.24) and intervention satisfaction (Cohen d=0.30). For positive affect, the results suggested a benefit for depressive symptoms (Cohen d=−0.32), the number of sessions viewed (3.68), dietary adherence (Cohen d=0.16), and intervention satisfaction (Cohen d=0.25).

    Conclusions: Overall, our results support the use of a VLC diet intervention in adults with T2D. The addition of monthly (not daily) dietary self-monitoring, mindful eating, and positive affect skills training did not show a definitive benefit, but it is worth further testing.

    Trial Registration: ClinicalTrials.gov NCT03037528; https://clinicaltrials.gov/ct2/show/NCT03037528

    JMIR Diabetes 2023;8:e44295

    doi:10.2196/44295

    Keywords

    eHealth; type 2 diabetes; T2D; very low–carbohydrate diet; weight loss; glycemic control; text messages; self-monitoring 


    Type 2 diabetes (T2D) is one of the most prevalent contemporary public health problems in the United States. If the current trajectory of prevalence continues, 1 in 3 US adults will have T2D by 2050 [1]. Nutritional management is one of the cornerstones of T2D treatment, and several dietary approaches are recommended for T2D, including a very low–carbohydrate (VLC) diet [2]. For example, a report by the American Diabetes Association’s Nutrition Review Committee noted the benefits of a VLC diet and updated the policy guidelines to recommend that for people with T2D “...not meeting glycemic targets or where reducing antiglycemic medications is a priority, reducing overall carbohydrate intake with a low- or VLC eating plan is a viable approach” [3]. Physiologically, carbohydrate intake increases blood glucose levels, which, in turn, increase insulin secretion from the pancreas. Insulin then inhibits lipolysis and the subsequent release of fatty acids from cells [4]. Numerous studies indicate that VLC diets can be effective at improving glycemic control, reducing the need for glucose-lowering medications, and increasing weight loss in adults with T2D [5-8].

    However, long-term adherence to any behavioral intervention can be challenging, and the behavioral strategies that may help improve the outcomes of VLC interventions are unclear. In this trial, we screened 3 potentially effective supplemental behavioral strategies using a full factorial design. This was informed by the Multiphase Optimization Strategy framework [9]. This approach suggests that before conducting large clinical trials of multicomponent interventions, particular aspects of the intervention should be tested, especially those that might be costly, burdensome, or simply have not been previously tested enough to be clearly appropriate for a particular intervention. Such an approach is becoming more common in behavioral intervention development, for example, in the areas of weight loss [10], physical activity promotion [11], and our previous pilot study of the VLC diet for adults with T2D [12].

    In this trial, we examined 3 supplemental strategies that were low-cost and varied in their degree of burden and level of previous testing. The first strategy we tested was dietary self-monitoring, wherein we varied whether we encouraged participants to practice dietary self-monitoring daily versus monthly (with monthly being defined as monitoring one’s diet in bursts of 3 days every 4 weeks). Weight loss trials involving dietary changes typically encourage daily dietary self-monitoring, as this can help people become more aware of their dietary adherence, and it tends to be associated with weight loss [13]. However, people commonly dislike daily monitoring, and their adherence to it tends to fade over time [14,15]. Thus, we compared daily versus monthly dietary self-monitoring, as a monthly amount may still be able to help participants self-regulate their dietary intake but in a less burdensome manner. To our knowledge, this is the first trial to randomize participants to different frequencies of the same type of dietary self-monitoring.

    The second strategy we assessed was mindful eating. We included exercises to increase awareness of the physical, cognitive, and emotional triggers of overeating; the awareness of internal cues that signal hunger, fullness, and taste satisfaction; “surfing” the urges to reduce emotional eating; and the cultivation of healthier alternatives [16,17]. The materials included, for example, a guided mindful eating exercise, a guided mini meditation to try before meals, and a hunger awareness exercise. We also included more general mindfulness topics, including how to respond versus react to situations. These approaches aim to help participants become more aware of their hunger-related bodily sensations, food cravings, and eating triggers, so that they can choose to respond more deliberately. Previous research has shown that mindful eating training helps reduce emotional eating, which is an important barrier for dietary adherence [18,19], and evidence suggests that increased mindful eating is associated with decreased fasting glucose levels in participants of a mindful eating weight loss intervention [20]. However, these strategies require extra time and attention from participants, which could be burdensome.

    The third strategy we tested was positive affect skills training, whose goal was to increase the frequency that participants experienced positive emotions. We taught participants skills such as noticing and savoring positive events, gratitude, acts of kindness, positive reappraisal, applying one’s personal strengths, and setting attainable goals [21]. To adhere to any dietary intervention, participants need to effectively cope with life stressors, and according to the revised Stress and Coping Theory [22,23], positive affect can serve as a psychological time-out from stress and increase adaptive coping [24-26]. Moreover, interventions that increase the experience of positive affect can reduce depressive symptoms, anxiety, and stress [27], which themselves may decrease treatment adherence [28]. Positive affect training may improve dietary adherence to the prescribed diet, which can be challenging. Dietary adherence, in this setting, requires participants to cope both emotionally and cognitively without using food-based coping strategies that they may have used in the past. For example, participants must (1) follow external instructions about what to eat and when to do so multiple times a day; (2) maintain supplies of appropriate foods in their homes, workplaces, and social gatherings, which requires planning, negotiating with others, and food refusal skills; (3) follow a way of eating that significant others may not follow or support, which can be isolating and frustrating; (4) plan financially for meals and snacks that other household members might reject or could lead to increased financial stress; (5) override any personal preferences for food or food-based rituals that they might have (such as eating chips at a restaurant or eating popcorn at movie theaters), which are not consistent with their new way of eating; and (6) overcome typical urges to eat when stressed or bored. In addition, hedonic theories of behavior propose that people do more of what they enjoy [29], possibly because positive emotional responses to behaviors increase the motivation and nonconscious desire to engage in those behaviors [30,31], so participants may be more likely to engage in an intervention that they enjoy. Similarly, previous research has demonstrated an association between higher eating plan satisfaction rates and adherence [32,33]. However, as with the mindful eating skills, the positive affect skills require extra time and attention from participants, which could be burdensome.

    The primary aim of this study was to assess whether 3 supplementary strategies (daily vs monthly dietary self-monitoring, mindful eating, and positive affect skills training) could improve outcomes in this VLC intervention with adults with T2D.


    Ethics Approval

    The institutional review board at the University of Michigan approved this research (HUM00115537).

    Participants

    This study was registered at ClinicalTrials.gov (NCT03037528). We recruited participants between February 4, 2017, and February 28, 2020, and completed data collection by June 4, 2021. We placed advertisements or notices of the research on the web (including Craigslist, University of Michigan’s web-based portal for clinical trials, and ResearchMatch) and sent invitation letters to potentially eligible participants identified from the health plan records at Michigan Medicine. Interested prospective participants were directed to the study website, which contained the University of Michigan logo, pertinent study information, and a link to a web-based self-reporting screening survey (Qualtrics). Those who were eligible for further screening based on their survey responses were asked to provide web-based electronic consent for the trial and subsequently to complete a second web-based survey (Qualtrics) that included the 8-item Patient Health Questionnaire (PHQ-8) to measure depressive symptoms [34]; a fingerstick self-collected mail-in blood test kit for hemoglobin A1c (HbA1c) test from DTI Laboratories, Inc, a Clinical Laboratory Improvement Amendments Certified Reference Laboratory [35]; and 3 days of dietary self-monitoring [36]. We also mailed participants a body weight scale that was connected to their own cellular network (BodyTrace).

    Eligibility Criteria

    Prospective participants were invited to enroll if they were aged 21 to 70 years, had a baseline HbA1c of ≥6.5%, had a BMI of 25-45 kg/m2 (based on self-reported height and measured weight from the study-provided scale), had regular access to the internet, were willing to check their email at least once a week, were comfortable reading and writing in English, had no potentially serious comorbidities such as liver or kidney failure, were planning on living in the United States for the duration of the trial, were not vegetarian or vegan, were not on weight loss medications, and were not taking warfarin or lithium. We also excluded people who were pregnant or breastfeeding, had an untreated thyroid condition, had an untreated mental health condition, had undergone weight loss surgery in the previous year, or were undergoing cancer treatments. Given that this study was conducted remotely, to mitigate the risk of hypoglycemia, we excluded participants who reported taking any antiglycemic medications other than metformin. Participants who met all the eligibility criteria following the screening process were invited to participate in the trial. They consented using an approved web-based consent form that described the study procedures and goals.

    Trial Design

    This 2×2×2 full factorial experimental design examined the impact of 3 experimental, 2-level supplementary strategies. The factorial trial design allows the entire trial population to be used to assess the effects of each factor on the outcome, allowing the efficient assessment of multiple behavioral factors in a single trial [37]. In this design, analysis is conducted to estimate the main effect of each factor by comparing outcomes between combinations of experimental conditions that match, except for the factor whose main effect is being estimated, and combining results across each set of matching combinations, for example, the main effect of including positive affect skills is essentially the difference between conditions (1 – 2) + (3 – 4) + (5 – 6) + (7 – 8; Table 1). Once all baseline measurements had been completed, the study staff randomized the participants to 1 of the 8 combinations of experimental conditions (Table 1) using a computer program to reveal the next assignment. The order was created using block randomization procedures, with blocks randomly allocated to size 8 or 16 and with the seed numbers used for randomization of 64655102233242, 64655183677600 from the Sealed Envelope website [38]. We stratified the randomization by gender.

    Some participants were amid their participation in the trial when the COVID-19 outbreak occurred in the United States (30/112, 26.8%). As the intervention was already completely remote, we were able to continue with the trial; however, this may have affected the outcomes.

    Table 1. Experimental conditions and levels of experimental supplemental strategies.
    Experimental conditionCore interventionDaily dietary self-monitoring frequencyMindful eatingPositive affect skills
    1YesYes or dailyYesYes
    2YesYes or dailyYesNo
    3YesYes or dailyNoYes
    4YesYes or dailyNoNo
    5YesNo or monthlyYesYes
    6YesNo or monthlyYesNo
    7YesNo or monthlyNoYes
    8YesNo or monthlyNoNo

    Core Intervention

    Once participants were assigned to the different intervention strategies, we emailed all participants links to the core intervention on the web, primarily educational VLC intervention materials throughout the 12-month intervention, weekly for the first 4 months, and then every 2 weeks for the remaining 8 months, for a total of 32 emails. Each of the 32 sets of materials focused on a different topic related to following a VLC diet. The emailed links connected participants to (1) a short survey to assess intervention-related dietary adherence and any health concerns; (2) a short, embedded video teaching session topic (eg, managing their diet during holidays or shifting particular meals to be VLC); (3) downloadable handouts to accompany the video; and (4) links to external web-based resources supporting session topics. Transcripts of the embedded videos were also provided.

    All participants received the same core, web-based nutritional intervention. This taught participants to eat a VLC diet based on our previous protocol [12], which aimed to limit carbohydrate intake to between 20 and 35 nonfiber grams of carbohydrates per day with the goal of achieving nutritional ketosis. A positive urine dipstick (Bayer Ketostix, which measures ketone acetoacetate) was used as an indicator of nutritional ketosis. Participants were advised to follow a diet that included meat, fish, cheese, eggs, fats, nuts, seeds, and low-carbohydrate vegetables and eliminated starchy and sugary foods. Participants also had email access to a dietary coach (either author KR or MP), as coaches have generally been found to be effective additions to behavioral interventions [39]. Both coaches had extensive experience with the VLC diet, and all messages were checked for fidelity by the first author, LRS, before being sent. Whenever the participants emailed questions to the coaches, they would receive prompt responses with support and resources. Overall, the coaches emailed participants a minimum of every 2 weeks. The participants also received a body weight scale at the start of their participation, and we asked the participants to monitor their body weight regularly, aiming for weighing themselves at least weekly. Coaches used this information to monitor participant success and tailor support. Starting from week 6 of the intervention, we provided goals for physical activity and sleep. Using the Diabetes Prevention Program [40] as a guide, we encouraged participants to be physically active for at least 150 minutes per week. We also encouraged participants to target 7-9 hours of total sleep per day. To encourage the adoption and maintenance of the new intervention-related behaviors, we sent participants text messages up to 5 times a week about the targeted behaviors and skills, depending on which supplemental strategies they were randomized to, as reminders about targeted behaviors are tied to greater behavioral adherence [41]. To help participants change their dietary patterns, we mailed the following cookbooks to participants: Keto Living 3 Cookbook: Lose Weight with 101 All New Delicious and Low Carb Ketogenic Recipes [42] at baseline; Bacon & Butter, the Ultimate Ketogenic Diet Cookbook [43] at month 3; The Wicked Good Ketogenic Diet Cookbook: Easy, Whole Food Keto Recipes for Any Budget [44] at month 6; and The Everyday Ketogenic Kitchen With More Than 150 Inspirational Low-Carb, High-Fat Recipes to Maximize Your Health [45] at month 10. As an incentive for continued participation, we paid participants US $25 for completing their outcome measurements at 4 months, US $25 at 8 months, and US $50 at 12 months.

    Experimental Supplemental Strategies

    Overview

    We randomized the participants to receive a VLC diet and 1 of the 8 possible combinations of the 3 supplemental strategies: dietary self-monitoring, mindful eating, or positive affect skills. The program materials were modified for each supplemental strategy, including different content added to the videos, handouts, and text messages. Participants were aware of the study design, but we did not explicitly state that participants were in the on or off group of each behavioral strategy.

    Dietary Self-monitoring

    All participants were asked to self-monitor their diet using the free web-based or mobile app MyFitnessPal [46], which has a wide variety of foods in its database that are common to the diet assigned in this trial (reducing participant burden and increasing accuracy). Participants were randomized to track their diet either daily or monthly (defined as 3 days every 4 weeks).

    Mindful Eating Skills

    Roughly half of the participants were randomized to training in mindful eating, how to practice the skills in everyday life, research supporting the use of the skills, how and why the skills were expected to help, and targeted suggestions for practicing these skills. We asked participants to focus on consciously savoring their food; eating more slowly; and noticing the textures, flavors, and aromas of their food more carefully. For example, during 1 session, we asked them to practice slowly savoring their food with a snack and encouraged them to practice this skill for at least 1 meal per day over the following week. Multimedia Appendix 1 provides an example handout [47-49].

    Positive Affect Skills

    Roughly half of the participants were randomized to receive training in positive affect skills. They were taught how to practice these skills in everyday life, informed about research supporting the use of the skills, how and why the skills were expected to help, and provided with targeted suggestions for practicing the skills. The skills we taught included noticing and savoring positive events, gratitude, positive reappraisal, and setting attainable goals, similar to our previous research [21]. Multimedia Appendix 1 provides an example handout.

    Assessments

    We conducted the following assessments for 1 primary outcome (HbA1c), 2 secondary outcomes (weight and depressive symptoms), and several exploratory outcomes (sessions viewed, dietary adherence, intervention satisfaction, metformin use, and qualitative feedback).

    Glycemic Control

    We measured our primary outcome, change in glycemic control at 12 months from baseline, with an at-home HbA1c kit (DTI Laboratories, Inc). The company was masked to the intervention design.

    Weight

    We assessed 1 of our secondary outcomes, change in percent body weight at 12 months from baseline, using the scale we had mailed to participants (BodyTrace). The company was blinded to the intervention design. We asked the participants to stand on the scale twice in 5 minutes at each period, and we used the average of these 2 measurements as their recorded weight.

    Depressive Symptoms

    We assessed 1 of our secondary outcomes, change in depressive symptoms at 12 months from baseline, using the PHQ-8 [34]. This was part of a web-based survey (Qualtrics), which was masked to the intervention design.

    Sessions Viewed

    We tracked the total number of sessions that were viewed by participants.

    Dietary Adherence

    With each session, we asked whether, based on self-assessment, participants were following a VLC diet rated from 1=“not at all” to 7=“very much so,” and we used the average of these ratings as an indicator of self-reported dietary adherence.

    Intervention Satisfaction

    At month 12, we asked participants, “How would you rate your overall satisfaction with the program?” (response options ranged from 1=“not at all satisfied” to 7=“very satisfied”), similar to previous research [50]. This was part of a web-based survey (Qualtrics).

    Metformin Use

    We considered a participant to have changed their metformin dose at 12 months if they reported such a change in their surveys, using the most recent description of the changes as their outcome in the trial.

    Qualitative Feedback

    We asked participants, using open-ended survey questions, about their thoughts about the intervention itself, their health changes, and the responses they had previously received from their physicians. The questions included, “Do have any overall suggestions for improving anything about the program or study?,” “Do have any suggestions about how we can improve how and how much people track what they are eating?”, “Please describe any changes in your medical issues since starting the study. Have they gotten better or worse since starting the study?” and “Have you gotten any feedback from family, friends, or physicians/health care providers about this program or your experience with it? If so, what did they say?”

    Statistical Analysis

    To assess the 12-month intervention changes, we conducted complete case analyses, excluding participants who did not complete the relevant 12-month assessment. Collapsing across all participants, we examined pre-post changes in HbA1c (our primary outcome), percent weight, PHQ-8, number of sessions participants viewed, self-reported dietary adherence, and intervention satisfaction, using between subjects 2-tailed t tests with SPSS (version 28.0; IBM Corp). We explored the outcomes using intent-to-treat analyses (n=112) with linear mixed regression models using SPSS. This approach makes use of all available data at the baseline and 12-month time points, with the outcomes as dependent variables, time (pre and post), and all 3 strategies in a full factorial design. We explored the overall changes across strategies using within-subjects t tests with SPSS. For the qualitative results, we examined open-ended comments and summarized common themes and exemplar quotes.

    Sample size calculations were performed using an SAS macro written by Dziak et al [51], designed for factorial trials. Our goal was to screen for supplemental strategies that had at least a medium effect size (Cohen d=0.5; Cohen suggested that a small effect size was 0.2, a medium effect size was 0.5, and a large effect size was 0.8). In addition, we planned to explore whether HbA1c and weight changed by a clinically meaningful amount: a reduction by a unit of 0.5% for HbA1c [52] and 3% to 5% reduction in weight [53]. The sample size was also estimated using a desired power of 0.8, a 2-tailed P value of .05, and a pretest-posttest correlation of HbA1c (the primary outcome of interest) of between 0.30 and 0.40 (based on pilot data). This led to a sample size goal of 108 to 117 of analyzable cases, which, with a planned attrition rate of 20%, would be 130 to 140 randomized participants. Therefore, our final sample size of 112 was slightly underpowered, after attrition, to detect changes between strategies based on our sample size estimates.


    We screened 793 potential participants, 112 (14.1%) of whom were randomized (Figure 1). Common reasons for exclusion included being nonresponsive or not completing enrollment steps (n=259), taking an excluded medication such as a nonmetformin antiglycemic medication (n=236), not having T2D or not having an HbA1c measurement in range (n=214), a diet-related issue such as already following a VLC diet (n=37), having an excluded health condition such as an untreated mental illness (n=52), or some other issues such as participating in another study already (n=35). At baseline, participants were on average aged 54.1 (SD 9.6) years, with a BMI of 35.0 (SD 5.1) kg/m2 and an HbA1c level of 7.5% (SD 1.1%), and 22.7% (25/110) of the participants had elevated depressive symptoms at baseline according to the PHQ-8. Most patients were White (81/112, 72.3%) and non-Hispanic (108/112, 96.4%; Table 2). We also compared the participants who dropped out and those who did not for these baseline variables (Table 2). No serious adverse events were reported during the trial.

    ‎
    Figure 1. A CONSORT (Consolidated Standards of Reporting Trials) diagram depicting participant flow through the study. HbA1c: hemoglobin A1c.
    Table 2. Baseline participant characteristics by strategy level (N=112).
    Experimental supplemental strategyAge (years), mean (SD)Gender (female), n (%)Hemoglobin A1c (%), mean (SD)BMI (kg/m2), mean (SD)Depressed, n (%)Race, n (%)Ethnicity, n (%)






    		WhiteAAaOtherHispanicNot Hispanic
    Overall (n=112)54.1 (9.6)80 (71.4)7.5 (1.1)35.0 (5.1)61 (54.5)81 (72.3)25 (22.3)7 (6.3)3 (2.7)108 (96.4)
    Daily dietary self-monitoring

    		Yes (n=57)52.3 (10.3)41 (71.9)7.3 (0.9)35.5 (5.2)29 (50.9)42 (73.7)13 (22.8)3 (5.3)1 (1.8)56 (98.2)

    		No (n=55)55.9 (8.7)39 (70.9)7.7 (1.2)34.7 (5.1)32 (58.2)39 (70.9)12 (21.8)4 (7.3)2 (3.6)52 (94.5)
    Mindful eating

    		Yes (n=57)53.1 (9.2)40 (70.2)7.5 (1.2)35.0 (5.5)32 (56.1)44 (77.2)10 (17.5)4 (7.0)1 (1.8)56 (98.2)

    		No (n=55)55.0 (10.1)40 (72.7)7.5 (1.0)35.1 (4.8)29 (52.7)37 (67.3)15 (27.2)3 (5.5)2 (3.6)52 (94.5)
    Positive affect

    		Yes (n=56)54.7 (9.2)41 (73.2)7.4 (1.1)35.7 (5.3)30 (53.6)37 (66.1)14 (25.0)5 (8.9)0 (0.0)55 (98.2)

    		No (n=56)53.4 (10.1)41 (73.2)7.6 (1.1)34.4 (4.9)31 (55.4)44 (78.6)11 (19.6)2 (3.6)3 (5.4)53 (94.6)
    Dropout

    		Yes (n=38)53.5 (10.7)28 (73.7)7.7 (1.3)34.9 (5.6)11 (28.9)26 (68.4)10 (26.3)2 (5.3)2 (5.3)36 (94.7)

    		No (n=73)54.4 (9.1)54 (73.9)7.4 (1.0)35.0 (4.9)14 (19.2)55 (75.3)17 (23.3)1 (1.4)1 (1.4)71 (97.3)

    aAA: African American.

    The gender of 1 participant was unknown. Participants could specify more than 1 race, and 1 person’s ethnicity was unknown.

    Table 3 summarizes the outcomes at 12 months for the complete case analyses, for which no results reached statistical significance and only 1 Cohen d point estimate reached 0.5: daily versus monthly dietary self-monitoring had a worse impact on change in depressive symptoms. For our primary outcome, change in HbA1c, the 95% CI overlapped with negligible benefit to significant harm for daily (vs monthly) dietary self-monitoring (−0.28% to 1.12%), with significant benefit to negligible harm for mindful eating (−1.15% to 0.22%), and with moderate benefit or harm for positive affect (−0.57% to 0.82%). Other results for daily (vs monthly) dietary self-monitoring were mixed, suggesting an increase in weight (0.98%) and depressive symptoms (Cohen d=0.47), less intervention satisfaction (Cohen d=−0.20), more sessions viewed (3.02), and greater dietary adherence (Cohen d=0.24). For mindful eating, the results suggested a benefit for dietary adherence (Cohen d=0.24) and intervention satisfaction (Cohen d=0.30). For positive affect, the results suggested a benefit for depressive symptoms (Cohen d=−0.32), the number of sessions viewed (3.68), dietary adherence (Cohen d=0.16), and intervention satisfaction (Cohen d=0.25).

    In the linear mixed models, the results of regressions predicting HbA1c, weight, and depressive symptoms were similar, and none of the factor × time interactions statistically significantly predicted outcomes (Multimedia Appendix 2).

    We also explored overall changes across the groups. In the complete case analyses, across all participants, HbA1c (−0.70%, 95% CI −1.04% to −0.35%; P<.001) and percent weight (−6.82, 95% CI −8.57 to −5.08; P<.001) improved by a clinically meaningful amount, and PHQ-8 dropped by a Cohen d with a medium effect size (−0.67, 95% CI −.92 to −.41; P<.001). Overall, 74.1% (83/112) of the participants were taking metformin at baseline. Although we made no medication management recommendations in the trial, by month 12, 30% (25/83) of the participants reduced or discontinued their metformin. None of the participants increased their antiglycemic medications.

    Table 3. Changes in outcomes from baseline to 12 months using complete case analysesa.
    Outcome and strategyYes, mean change (95% CI)No, mean change (95% CI)Yes versus no, mean difference (95% CI)Yes versus no, Cohen d (95% CI)P value
    Change in hemoglobin A1c (%)

    		Daily dietary self-monitoring (yes or daily, n=45; no or monthly, n=29)−0.53 (−0.96 to −0.11)−0.95 (−1.55 to −0.35)0.42 (−0.28 to 1.12)0.28 (−0.19 to 0.75).24

    		Mindful eating (yes, n=39; no, n=35)−0.92 (−1.43 to −0.40)−0.45 (−0.90 to 0.00)−0.47 (−1.15 to 0.22)−0.32 (−0.78 to 0.14).18

    		Positive affect (yes, n=40; no, n=34)−0.64 (−1.20 to −0.08)−0.76 (−1.14 to −0.39)0.12 (−0.57 to 0.82)0.08 (−0.37 to 0.54).72
    Change in percent body weight

    		Daily dietary self-monitoring (yes/daily, n=47; no/monthly, n=30)−6.45 (−8.78 to −4.11)−7.42 (−10.15 to −4.69)0.98 (−2.61 to 4.57)0.13 (−0.33 to 0.59).59

    		Mindful eating (yes, n=40; no, n=37)−7.22 (−9.42 to −5.02)−6.40 (−9.26 to −3.55)−0.81 (−4.32 to 2.70)−0.11 (−0.56 to 0.34).65

    		Positive affect (yes, n=41; no, n=36)−7.06 (−9.84 to −4.28)−6.56 (−8.68 to −4.44)−0.50 (−4.02 to 3.01)−0.07 (−0.51 to 0.38).78
    Change in depressive symptoms (PHQ-8b)

    		Daily dietary self-monitoring (yes or daily, n=43; no or monthly, n=27)−2.26 (−3.61 to −0.91)−4.33 (−6.13 to −2.53)2.08 (−0.13 to 4.29)0.47 (−0.02 to 0.95).06

    		Mindful eating (yes, n=37; no, n=33)−2.97 (−4.07 to −1.88)−3.15 (−5.16 to −1.14)0.18 (−2.00 to 2.36)0.04 (−0.43 to 0.51).87

    		Positive affect (yes, n=37; no, n=33)−3.73 (−5.51 to −1.95)−2.30 (−3.48 to −1.12)−1.43 (−3.58 to 0.73)−0.32 (−0.79 to 0.16).19
    Number of sessions viewed

    		Daily dietary self-monitoring (yes or daily, n=57; no or monthly, n=55)21.93 (19.30 to 24.56)18.91 (15.75 to 22.07)3.02 (−1.03 to 7.08)0.28 (−0.09 to 0.65).14

    		Mindful eating (yes, n=57; no, n=55)20.46 (17.49 to 23.38)20.44 (17.55 to 23.37)0.02 (−4.07 to 4.11)0.02 (−0.36 to 0.37).99

    		Positive affect (yes, n=56; no, n=56)22.29 (19.53 to 25.04)18.61 (15.60 to 21.62)3.68 (−0.36 to 7.71).34 (−0.03 to 0.71).07
    Self-reported dietary adherence

    		Daily dietary self-monitoring (yes or daily, n=56; no or monthly, n=53)4.87 (4.50 to 5.24)4.51 (4.05 to 4.97)0.36 (−0.22 to 0.94)0.24 (−0.14 to 0.61).22

    		Mindful eating (yes, n=55; no, n=54)4.87 (4.48 to 5.27)4.51 (4.07 to 4.94)0.37 (−0.21 to 0.95)0.24 (−0.13 to 0.62).21

    		Positive affect (yes, n=55; no, n=54)4.82 (4.40 to 5.23)4.56 (4.14 to 4.98)0.25 (−0.33 to 0.84)0.16 (−0.21 to 0.54).39
    12-month intervention satisfaction

    		Daily dietary self-monitoring (yes or daily, n=44; no or monthly, n=28)6.07 (5.66 to 6.48)6.32 (5.91 to 6.73)−0.25 (−0.86 to 0.35)−0.20 (−0.68 to 0.27).40

    		Mindful eating (yes, n=38; no, n=34)6.34 (5.99 to 6.69)5.97 (5.48 to 6.46)0.37 (−0.21 to 0.96)0.30 (−0.16 to 0.76).21

    		Positive affect (yes, n=38; no, n=34)6.32 (5.99 to 6.64)6.00 (5.48 to 6.52)0.32 (−0.29 to 0.92)0.25 (−0.21 to 0.72).29

    aResults from 2-sided t tests and P values are for the mean differences between receiving and not receiving the behavioral factor.

    bPHQ-8: 8-item Patient Health Questionnaire.

    We explored the participants’ perceptions of the 3 supplemental strategies using open-ended questions on the self-report survey at months 4, 8, and 12. Some participants had a positive experience with dietary self-monitoring, finding it to be helpful (“Tracking forced me to measure and that was an eye-opener at times.”). Others noted that it was difficult to motivate themselves to self-monitor (“It is so easy to eat too much when you don’t keep track, but for some reason I drag my heels on doing it.”), they avoided dietary self-monitoring when they ate food off of the assigned dietary approach (“I actually found myself tracking less especially when I know that I had gone over the carb limit—even a little.”), and reported that it could be difficult to use the app (“I still find MyFitnessPal hard to use. I ended up making my own list of foods I ate and still eat and refer to it often.”). Some participants felt daily tracking was tedious to do (“I hate, hate, hate the tediousness of inputting every freaking tablespoon of butter or every 1/4 cup of half and half or every miniscule morsel that goes into my mouth every day. So, I only actually input that info once a week or so.”), or found it was easy to forget to do (“...I forget about doing it [tracking] and then I forget what I have eaten.”). Participants also felt it was unnecessary to do once they understood what to eat (“I was really good at it in the beginning but once I felt I knew what to do, it just felt too time consuming.”), and it was challenging to keep up long term (“I tracked very well for the first 4 months and then burned out.”). Participants recommended that dietary self-monitoring a couple of times a week would have been ideal. For example, for those in the daily dietary self-monitoring condition, daily self-monitoring may have been too often. One person in the daily self-monitoring condition suggested the following:

    I would suggest tracking no more than 3 times a week. Then it wouldn’t be so time consuming.

    For those in the monthly self-monitoring condition, self-monitoring only monthly may not have been sufficient. Someone else in the monthly self-monitoring condition suggested the following:

    If you tell me I have to track I will, if it’s my choice I won’t. So, [ask participants] to track 1-2 days a week, every week.

    The participants also commented on the mindful eating and positive affect skills. Participants who were assigned to both mindful eating and positive affect skills noted the following:

    I liked the other parts of this program. Breathing, self-meditation, doing good for others.
    The psychological challenges were good, but I was already familiar with most of them.

    One participant who received mindful eating and positive affect skills noted that the text messages about those skills were “...quite annoying. Personally, I don’t need that type of encouragement.” Thoughts were specifically mixed regarding mindful eating. One participant described the following:

    My least favorite subject was the whole mindful eating thing—a bit squishy for me. I’m sure some people love it, but just not my cup of tea. I just can’t see getting so connected with the process. However, I have started eating like a European—slows you down a bit.

    One person noted, “Mindfulness was valuable to me.” Another person assigned to receive mindful eating text messages noted the following:

    Sometimes if I feel like cheating, I’d get a text. It was great to get a reminder and encouragement not to give in to the sweets and to stick with what I am doing. It’s like you are all out there rooting me on every day, having a personal cheerleader through text messages.

    Another participant noted the following:

    The support and psychological skills have made me want to try to stick with it, just to get those benefits.

    We examined the qualitative comments regarding other changes and their impacts. Other notable health and medication changes were described by participants:

    I no longer take Metformin XR, tums/Rolaids, or the anti-inflammatory medications I was taking for my Ankylosing Spondylitis.
    I was going to need a CPAP [continuous positive airway pressure] machine for sleep apnea, but the sleep apnea is gone!!

    Another participant commented the following:

    When I was diagnosed with diabetes, I felt kind of hopeless. I imagined a life of more and more medication and complications from diabetes. Now I have hope that there is another way, and I’m very thankful.

    Participants noted that the physicians were generally supportive:

    My internist was floored by my bloodwork results and weight loss...
    My doctor calls me her poster child of diabetes. She can’t believe I’ve made the decision from the moment I was diagnosed to not take the metformin, and instead take the harder path of changing my diet to keep my body under control. She applauds my willpower, but to me, if they told me I had cancer, I’d do whatever it took to live. This disease is no different.

    Principal Findings

    This study addressed different ways to improve outcomes in a web-based VLC intervention for adults with T2D by using the Multiphase Optimization Strategy framework to examine which of the 3 potentially helpful supplemental behavioral strategies significantly contributed to reduced HbA1c and other outcomes. Overall, the VLC intervention led to statistically significant improvements in glycemic control, weight loss, and depressive symptoms. However, none of the 3 strategies had a statistically significantly different effect on outcomes, and only 1 Cohen d point estimate reached our targeted level of 0.5: daily (vs monthly) dietary self-monitoring, such that greater dietary self-monitoring frequency was associated with increased depressive symptoms.

    More specifically, we found mixed results for daily dietary self-monitoring. The 95% CIs suggested that daily dietary self-monitoring may be less effective at reducing HbA1c levels than monthly dietary self-monitoring, which may also be less effective at reducing body weight and improving depressive symptoms but more effective at increasing the number of sessions viewed and increasing self-reported dietary adherence. The results also suggest that daily (vs monthly) dietary self-monitoring had lower intervention satisfaction. Our mixed results regarding dietary self-monitoring were echoed in the qualitative feedback, which suggested that participants found frequent (daily vs monthly) self-monitoring to be useful but burdensome. Similarly, previous qualitative research on participants’ experiences with dietary self-monitoring found comparable complaints, such as the experience of tedium [54]. In a study of dietary self-monitoring with MyFitnessPal, approximately half of the participants experienced increased negative emotions [55], and focus groups have found that people dislike dietary self-monitoring apps [56].

    Our results suggest that monthly versus daily dietary self-monitoring may improve participant outcomes. Notably, our results contrast with a recent review, which found that 80% (16/20) of the trials found that the more participants self-monitored their diet, the greater was their weight loss. However, the results of the review were correlational, describing how participants’ behavior was associated with the outcomes [57]. As the review described, “no known published, digital weight loss trials randomized participants to varying frequencies of self-monitoring” [57]. Therefore, to our knowledge, this is the first trial to randomize participants to different frequencies of the same type of dietary self-monitoring.

    For mindful eating, for our primary outcome of change in HbA1c, the 95% CI overlapped with a significant benefit to negligible harm, and other results suggested a possible moderate benefit for dietary adherence and intervention satisfaction. This aligns with previous research, such as a systematic review finding that in randomized trials, mindfulness-based interventions reduced HbA1c levels [58] and another review finding that mindfulness-based interventions may improve medication adherence [59].

    The positive affect skills had no detectable impact on changes in HbA1c levels or percent body weight. However, the 95% CIs for positive affect suggest a moderate benefit for changes in depressive symptoms, number of sessions viewed, dietary adherence, and intervention satisfaction. These results align with previous research, such as the finding that positive affect interventions can reduce depressive symptoms, anxiety, and stress [27], including in adults with T2D [21], and that positive affect has been positively correlated with medication adherence [60]. In observational studies, positive affect was associated with better health outcomes including viral load suppression in people living with HIV [61] and better physical function during recovery from stroke, heart attack, or hip fracture [62]. Positive affect is associated with better health behaviors such as physical activity [63-65] and better medication adherence among people living with chronic illnesses [60]. The Positive Pathways to Health theoretical model [66] posits that interventions that increase positive affect have a host of proximal effects including providing a time-out from stress, encouraging more adaptive coping strategies, broadening attention and cognition, reducing reactivity to daily stress, and enhancing social relationships. These proximal effects, in turn, lead to improved health behaviors and better psychological and physical well-being.

    Overall, across all conditions, the core VLC diet intervention for adults with T2D led to improved glycemic control, weight loss, and reductions in antiglycemic medication, replicating previous results in adults with T2D [12,67-70]. Participants’ depressive levels were also reduced, replicating some previous research on a VLC diet in adults with T2D [71], although in 1 of our previous trials, we did not find a statistically significant reduction in depressive symptoms [68].

    Limitations and Strengths

    Our study has several limitations and strengths. A limitation of the trial was that 80% of the sample were women, 81% were White, and 96% were non-Hispanic, which limits our ability to understand the impact of these supplementary approaches in a more representative sample. Another limitation of the trial was that 27% of the participants were in the trial when COVID-19 began in the United States in 2020; therefore, our conclusions about which supplementary strategies might be most helpful may have been influenced by this. The supplementary strategies all involve self-control, time, and planning to practice regularly. During the pandemic, some people experienced disruptions in their daily routines, such as increased stress, anxiety, and depressive symptoms; financial stress; and social isolation, all of which may have made practicing the supplemental strategies more challenging. Given budgetary limitations, we did not use a gold standard method of tracking dietary adherence, such as 24-hour dietary recalls, but future research should do so when possible. Moreover, the qualitative section was merely an exploration of open-ended comments and not a rigorously conducted qualitative analysis; therefore, caution should be used when interpreting these results, and future research should use a more rigorous approach. In addition, partly because of COVID-19, we did not recruit our intended number of participants, so the trial was underpowered. Moreover, we could only test a finite set of supplementary strategies; therefore, we cannot generalize our conclusions beyond the strategies tested.

    A strength of the trial is its innovation, as it is one of the few trials thus far to conduct such a screening experiment, testing a variety of behavioral components, in a behavioral intervention for adults with T2D with HbA1c as an outcome. Another strength was that we were able to recruit participants nationally, enabling for a more nationally representative sample, as we required no in-person measurements. The web-based nature of the trial allowed participants to continue in the trial, regardless of the COVID-19 social distancing protocols. Moreover, because participants did not have to travel to attend the sessions and the sessions, coaching, and assessments occurred when the participants chose, this made participation more convenient and less costly. Finally, to the best of our knowledge, this is the first trial to randomize participants to different frequencies of the same type of dietary self-monitoring.

    Conclusions

    Our study was designed to test whether several supplemental behavioral strategies (daily vs monthly dietary self-monitoring, mindful eating skills, and positive affect skills) could improve glycemic control and other outcomes in adults with T2D who were recommended to follow a VLC diet. Overall, we found that none of the 3 selected supplemental strategies under consideration resulted in statistically significant changes. However, for changes in our primary outcome of 12-month HbA1c, the 95% CI overlapped with clinically meaningful improvements in glycemic control for monthly (vs daily) dietary self-monitoring and for mindful eating skills (vs no such skills). The addition of monthly (not daily) dietary self-monitoring, mindful eating, and positive affect skills training did not show a definitive benefit, but it is worth further testing. For example, other future tests could use more intensive versions of the behavioral strategies, such as weekly video-based meetings with a coach who actively guides participants through the strategies, or the strategies could be tested with participants with other health conditions, risk factors, or sociocultural needs. Overall, our results support the use of a VLC diet intervention in adults with T2D.

    Acknowledgments

    The authors would like to thank the dedicated participants as well as Linda Collins, Caroline Richardson, John Piette, Michele Heisler, Charles Burant, and Robert Ploutz-Snyder.

    Conflicts of Interest

    LRS and this research were supported by a K01 award from the National Institutes of Health (NIDDK, NIH), DK107456, from the National Institute of Diabetes and Digestive and Kidney Diseases. JTM was supported by NIH grant K24 MH093225 from the National Institute of Mental Health. FMH was supported by NIH grant K24 AT007827 from the National Center for Complementary and Integrative Health. AEM was supported by the National Heart, Blood, and Lung Institute (NHLBI, NIH), K23HL133442. ALM was supported as a Robert Wood Johnson Foundation Future of Nursing Scholar. LRS’s partner, HB, is an inventor of software used in this study, which purchased a software services agreement for its use. LRS received funding from Sentinel Management, Milken Foundation, and the Baszucki Brain Research Fund to support research on the impact of a ketogenic diet for severe mental illness. The other authors have no conflicts of interest to declare. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.

    ‎
    Multimedia Appendix 1

    Example educational materials.

    PDF File (Adobe PDF File), 3355 KB
    ‎
    Multimedia Appendix 2

    Change in outcomes from baseline to 12 months using intent-to-treat analyses from linear mixed models.

    PDF File (Adobe PDF File), 32 KB
    ‎
    Multimedia Appendix 3

    CONSORT-eHEALTH checklist (V 1.6.1).

    PDF File (Adobe PDF File), 1280 KB
    1. Boyle JP, Thompson TJ, Gregg EW, Barker LE, Williamson DF. Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence. Popul Health Metrics 2010 Oct 22;8(1):29. [CrossRef] [Medline]
    2. Forouhi NG, Misra A, Mohan V, Taylor R, Yancy W. Dietary and nutritional approaches for prevention and management of type 2 diabetes. BMJ 2018 Jun 13;361:k2234 [FREE Full text] [CrossRef] [Medline]
    3. Evert AB, Dennison M, Gardner CD, Garvey WT, Lau KH, MacLeod J, et al. Nutrition therapy for adults with diabetes or prediabetes: a consensus report. Diabetes Care 2019 May;42(5):731-754 [FREE Full text] [CrossRef] [Medline]
    4. Hite AH, Berkowitz VG, Berkowitz K. Low-carbohydrate diet review: shifting the paradigm. Nutr Clin Pract 2011 Jun;26(3):300-308. [CrossRef] [Medline]
    5. Kirk JK, Graves DE, Craven TE, Lipkin EW, Austin M, Margolis KL. Restricted-carbohydrate diets in patients with type 2 diabetes: a meta-analysis. J Am Diet Assoc 2008 Jan;108(1):91-100. [CrossRef] [Medline]
    6. Nielsen JV, Joensson E. Low-carbohydrate diet in type 2 diabetes. Stable improvement of bodyweight and glycemic control during 22 months follow-up. Nutr Metab (Lond) 2006 Jun 14;3:22 [FREE Full text] [CrossRef] [Medline]
    7. Accurso A, Bernstein RK, Dahlqvist A, Draznin B, Feinman RD, Fine EJ, et al. Dietary carbohydrate restriction in type 2 diabetes mellitus and metabolic syndrome: time for a critical appraisal. Nutr Metab (Lond) 2008 Apr 08;5:9 [FREE Full text] [CrossRef] [Medline]
    8. Santos FL, Esteves SS, da Costa Pereira A, Yancy Jr WS, Nunes JP. Systematic review and meta-analysis of clinical trials of the effects of low carbohydrate diets on cardiovascular risk factors. Obes Rev 2012 Nov;13(11):1048-1066. [CrossRef] [Medline]
    9. Collins LM. Optimization of Behavioral, Biobehavioral, and Biomedical Interventions: The Multiphase Optimization Strategy (MOST). Cham, Switzerland: Springer; 2018.
    10. Spring B, Pfammatter AF, Marchese SH, Stump T, Pellegrini C, McFadden HG, et al. A factorial experiment to optimize remotely delivered behavioral treatment for obesity: results of the Opt-IN study. Obesity (Silver Spring) 2020 Sep;28(9):1652-1662 [FREE Full text] [CrossRef] [Medline]
    11. Phillips SM, Penedo FJ, Collins LM, Solk P, Siddique J, Song J, et al. Optimization of a technology-supported physical activity promotion intervention for breast cancer survivors: results from Fit2Thrive. Cancer 2022 Mar 01;128(5):1122-1132 [FREE Full text] [CrossRef] [Medline]
    12. Saslow LR, Moskowitz JT, Mason AE, Daubenmier J, Liestenfeltz B, Missel AL, et al. Intervention enhancement strategies among adults with type 2 diabetes in a very low-carbohydrate web-based program: evaluating the impact with a randomized trial. JMIR Diabetes 2020 Sep 09;5(3):e15835 [FREE Full text] [CrossRef] [Medline]
    13. Raber M, Liao Y, Rara A, Schembre SM, Krause KJ, Strong L, et al. A systematic review of the use of dietary self-monitoring in behavioural weight loss interventions: delivery, intensity and effectiveness. Public Health Nutr 2021 Dec;24(17):5885-5913 [FREE Full text] [CrossRef] [Medline]
    14. Burke LE, Styn MA, Sereika SM, Conroy MB, Ye L, Glanz K, et al. Using mHealth technology to enhance self-monitoring for weight loss: a randomized trial. Am J Prev Med 2012 Jul;43(1):20-26 [FREE Full text] [CrossRef] [Medline]
    15. Yon BA, Johnson RK, Harvey-Berino J, Gold BC, Howard AB. Personal digital assistants are comparable to traditional diaries for dietary self-monitoring during a weight loss program. J Behav Med 2007 Apr;30(2):165-175. [CrossRef] [Medline]
    16. Forman EM, Butryn ML, Manasse SM, Crosby RD, Goldstein SP, Wyckoff EP, et al. Acceptance-based versus standard behavioral treatment for obesity: results from the mind your health randomized controlled trial. Obesity (Silver Spring) 2016 Oct;24(10):2050-2056 [FREE Full text] [CrossRef] [Medline]
    17. Forman EM, Butryn ML. A new look at the science of weight control: how acceptance and commitment strategies can address the challenge of self-regulation. Appetite 2015 Jan;84:171-180 [FREE Full text] [CrossRef] [Medline]
    18. Mason AE, Lustig RH, Brown RR, Acree M, Bacchetti P, Moran PJ, et al. Acute responses to opioidergic blockade as a biomarker of hedonic eating among obese women enrolled in a mindfulness-based weight loss intervention trial. Appetite 2015 Aug;91:311-320 [FREE Full text] [CrossRef] [Medline]
    19. Mason AE, Epel ES, Aschbacher K, Lustig RH, Acree M, Kristeller J, et al. Reduced reward-driven eating accounts for the impact of a mindfulness-based diet and exercise intervention on weight loss: data from the SHINE randomized controlled trial. Appetite 2016 May 01;100:86-93 [FREE Full text] [CrossRef] [Medline]
    20. Mason AE, Epel ES, Kristeller J, Moran PJ, Dallman M, Lustig RH, et al. Effects of a mindfulness-based intervention on mindful eating, sweets consumption, and fasting glucose levels in obese adults: data from the SHINE randomized controlled trial. J Behav Med 2016 Apr;39(2):201-213 [FREE Full text] [CrossRef] [Medline]
    21. Cohn MA, Pietrucha ME, Saslow LR, Hult JR, Moskowitz JT. An online positive affect skills intervention reduces depression in adults with type 2 diabetes. J Posit Psychol 2014 Jan 01;9(6):523-534 [FREE Full text] [CrossRef] [Medline]
    22. Folkman S. Positive psychological states and coping with severe stress. Soc Sci Med 1997 Oct;45(8):1207-1221. [CrossRef] [Medline]
    23. Folkman S. The case for positive emotions in the stress process. Anxiety Stress Coping 2008 Jan;21(1):3-14. [CrossRef] [Medline]
    24. Lazarus R, Kanner AD, Folkman S. Emotions: a cognitive–phenomenological analysis. In: Plutchik R, Kellerman H, editors. Theories of Emotion. New York, NY, USA: Academic Press; 1980:189-217.
    25. Fredrickson BL, Joiner T. Positive emotions trigger upward spirals toward emotional well-being. Psychol Sci 2002 Mar;13(2):172-175. [CrossRef] [Medline]
    26. Moskowitz JT, Folkman S, Collette L, Vittinghoff E. Coping and mood during aids-related caregiving and bereavement. Ann Behav Med 1996 Mar;18(1):49-57. [CrossRef] [Medline]
    27. Carr A, Cullen K, Keeney C, Canning C, Mooney O, Chinseallaigh E, et al. Effectiveness of positive psychology interventions: a systematic review and meta-analysis. J Posit Psychol 2021;16(6):749-769 [FREE Full text] [CrossRef]
    28. Świątoniowska-Lonc N, Tański W, Polański J, Jankowska-Polańska B, Mazur G. Psychosocial determinants of treatment adherence in patients with type 2 diabetes - a review. Diabetes Metab Syndr Obes 2021 Jun 16;14:2701-2715 [FREE Full text] [CrossRef] [Medline]
    29. Williams DM. Exercise, affect, and adherence: an integrated model and a case for self-paced exercise. J Sport Exerc Psychol 2008 Oct;30(5):471-496 [FREE Full text] [CrossRef] [Medline]
    30. Fredrickson BL. Positive emotions broaden and build. Adv Exp Soc Psychol 2013;47(1):1-53 [FREE Full text] [CrossRef]
    31. Van Cappellen P, Rice EL, Catalino LI, Fredrickson BL. Positive affective processes underlie positive health behaviour change. Psychol Health 2018 Jan;33(1):77-97 [FREE Full text] [CrossRef] [Medline]
    32. Coyne T, Olson M, Bradham K, Garcon M, Gregory P, Scherch L. Dietary satisfaction correlated with adherence in the modification of diet in renal disease study. J Am Diet Assoc 1995 Nov;95(11):1301-1306 [FREE Full text] [CrossRef] [Medline]
    33. Ahlgren SS, Shultz JA, Massey LK, Hicks BC, Wysham C. Development of a preliminary diabetes dietary satisfaction and outcomes measure for patients with type 2 diabetes. Qual Life Res 2004 May;13(4):819-832. [CrossRef] [Medline]
    34. Kroenke K, Strine TW, Spitzer RL, Williams JB, Berry JT, Mokdad AH. The PHQ-8 as a measure of current depression in the general population. J Affect Disord 2009 Apr;114(1-3):163-173. [CrossRef] [Medline]
    35. Technical bulletin: capillary hemoglobin A1c performance characteristics. DTI Laboratories Inc. 2023.   URL: https://img1.wsimg.com/blobby/go/8124f010-9532-400d-983d-f17d576b4e5e/Technical%20Bulletin.pdf [accessed 2023-02-25]
    36. MyFitnessPal.   URL: https://www.myfitnesspal.com/ [accessed 2023-04-27]
    37. Collins LM, Dziak JJ, Kugler KC, Trail JB. Factorial experiments: efficient tools for evaluation of intervention components. Am J Prev Med 2014 Oct;47(4):498-504 [FREE Full text] [CrossRef] [Medline]
    38. Create a blocked randomization list. Sealed Envelope Ltd. 2015.   URL: https://www.sealedenvelope.com/simple-randomiser/v1/lists [accessed 2017-01-14]
    39. Kivelä K, Elo S, Kyngäs H, Kääriäinen M. The effects of health coaching on adult patients with chronic diseases: a systematic review. Patient Educ Couns 2014 Nov;97(2):147-157. [CrossRef] [Medline]
    40. Orchard TJ, Temprosa M, Goldberg R, Haffner S, Ratner R, Marcovina S, Diabetes Prevention Program Research Group. The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the diabetes prevention program randomized trial. Ann Intern Med 2005 Apr 19;142(8):611-619 [FREE Full text] [CrossRef] [Medline]
    41. Fry JP, Neff RA. Periodic prompts and reminders in health promotion and health behavior interventions: systematic review. J Med Internet Res 2009 May 14;11(2):e16 [FREE Full text] [CrossRef] [Medline]
    42. Coleman E, Burlington N. Keto Living 3 - Color Cookbook: Lose Weight with 101 All New Delicious & Low Carb Ketogenic Recipes. Albany, NY, USA: Visual Magic Productions; 2014.
    43. Richoux C. Bacon & Butter: The Ultimate Ketogenic Diet Cookbook. Berkeley, CA, USA: Rockridge Press; 2014.
    44. Hughes AC. Wicked Good Ketogenic Diet Cookbook: Easy, Whole Food Keto Recipes for Any Budget. New York, NY, USA: Callisto Media; 2016.
    45. Ketchum C. The Everyday Ketogenic Kitchen: With More than 150 Inspirational Low-Carb, High-Fat Recipes to Maximize Your Health. Las Vegas, NV, USA: Victory Belt Publishing; 2017.
    46. Yusof AF, Iahad NA. Review on online and mobile weight loss management system for overcoming obesity. In: Proceedings of the 2012 International Conference on Computer & Information Science. 2012 Presented at: ICCISci '12; June 12-14, 2012; Kuala Lumpur, Malaysia p. 198-203   URL: https://ieeexplore.ieee.org/document/6297239/authors#authors [CrossRef]
    47. Zautra AJ, Reich JW. Life events and perceptions of life quality: Developments in a two‐factor approach. J Commun Psychol 1983;11(2):121-132. [CrossRef]
    48. Murrell SA, Norris FH. Resources, life events, and changes in positive affect and depression in older adults. Am J Community Psychol 1984 Aug;12(4):445-464. [CrossRef] [Medline]
    49. Krause N. Positive life events and depressive symptoms in older adults. Behav Med 1988;14(3):101-112. [CrossRef] [Medline]
    50. O'Reilly H, Panizza CE, Lim U, Yonemori KM, Wilkens LR, Shvetsov YB, et al. Utility of self-rated adherence for monitoring dietary and physical activity compliance and assessment of participant feedback of the healthy diet and lifestyle study pilot. Pilot Feasibility Stud 2021 Feb 11;7(1):48 [FREE Full text] [CrossRef] [Medline]
    51. Dziak JJ, Collins LM, Wagner AT. FactorialPowerPlan SAS macro users’ guide, Version 1.0. The Methodology Center, Penn State. 2013.   URL: https://cadio.org/wp-content/uploads/2022/08/factorial_power_plan_ug-1du7v00.pdf [accessed 2013-05-31]
    52. Dankers M, Nelissen-Vrancken MH, Hart BH, Lambooij AC, van Dijk L, Mantel-Teeuwisse AK. Alignment between outcomes and minimal clinically important differences in the Dutch type 2 diabetes mellitus guideline and healthcare professionals' preferences. Pharmacol Res Perspect 2021 May;9(3):e00750 [FREE Full text] [CrossRef] [Medline]
    53. Donnelly JE, Blair SN, Jakicic JM, Manore MM, Rankin JW, Smith BK, American College of Sports Medicine. American college of sports medicine position stand. Appropriate physical activity intervention strategies for weight loss and prevention of weight regain for adults. Med Sci Sports Exerc 2009 Feb;41(2):459-471. [CrossRef] [Medline]
    54. Burke LE, Swigart V, Warziski Turk M, Derro N, Ewing LJ. Experiences of self-monitoring: successes and struggles during treatment for weight loss. Qual Health Res 2009 Jun;19(6):815-828 [FREE Full text] [CrossRef] [Medline]
    55. Hahn SL, Linxwiler AN, Huynh T, Rose KL, Bauer KW, Sonneville KR. Impacts of dietary self-monitoring via MyFitnessPal to undergraduate women: a qualitative study. Body Image 2021 Dec;39:221-226 [FREE Full text] [CrossRef] [Medline]
    56. Solbrig L, Jones R, Kavanagh D, May J, Parkin T, Andrade J. People trying to lose weight dislike calorie counting apps and want motivational support to help them achieve their goals. Internet Interv 2017 Mar;7:23-31 [FREE Full text] [CrossRef] [Medline]
    57. Patel ML, Wakayama LN, Bennett GG. Self-monitoring via digital health in weight loss interventions: a systematic review among adults with overweight or obesity. Obesity (Silver Spring) 2021 Mar;29(3):478-499. [CrossRef] [Medline]
    58. Ni YX, Ma L, Li JP. Effects of mindfulness-based intervention on glycemic control and psychological outcomes in people with diabetes: a systematic review and meta-analysis. J Diabetes Investig 2021 Jun;12(6):1092-1103 [FREE Full text] [CrossRef] [Medline]
    59. Nardi WR, Loucks EB, Springs S, Operario D, Kronish IM, Gaudiano BA, et al. Mindfulness-based interventions for medication adherence: a systematic review and narrative synthesis. J Psychosom Res 2021 Oct;149:110585 [FREE Full text] [CrossRef] [Medline]
    60. Bassett SM, Schuette SA, O'Dwyer LC, Moskowitz JT. Positive affect and medication adherence in chronic conditions: a systematic review. Health Psychol 2019 Nov;38(11):960-974 [FREE Full text] [CrossRef] [Medline]
    61. Wilson TE, Weedon J, Cohen MH, Golub ET, Milam J, Young MA, et al. Positive affect and its association with viral control among women with HIV infection. Health Psychol 2017 Jan;36(1):91-100 [FREE Full text] [CrossRef] [Medline]
    62. Ostir GV, Goodwin JS, Markides KS, Ottenbacher KJ, Balfour J, Guralnik JM. Differential effects of premorbid physical and emotional health on recovery from acute events. J Am Geriatr Soc 2002 Apr;50(4):713-718. [CrossRef] [Medline]
    63. Emerson JA, Dunsiger S, Williams DM. Reciprocal within-day associations between incidental affect and exercise: an EMA study. Psychol Health 2018 Jan;33(1):130-143 [FREE Full text] [CrossRef] [Medline]
    64. Ryff CD, Singer BH, Dienberg Love G. Positive health: connecting well-being with biology. Philos Trans R Soc Lond B Biol Sci 2004 Sep 29;359(1449):1383-1394 [FREE Full text] [CrossRef] [Medline]
    65. Watson D. Intraindividual and interindividual analyses of positive and negative affect: their relation to health complaints, perceived stress, and daily activities. J Pers Soc Psychol 1988 Jun;54(6):1020-1030. [CrossRef] [Medline]
    66. Moskowitz JT, Addington EL, Cheung EO. Positive psychology and health: well-being interventions in the context of illness. Gen Hosp Psychiatry 2019 Nov;61:136-138. [CrossRef] [Medline]
    67. Saslow LR, Summers C, Aikens JE, Unwin DJ. Outcomes of a digitally delivered low-carbohydrate type 2 diabetes self-management program: 1-year results of a single-Arm Longitudinal Study. JMIR Diabetes 2018 Aug 03;3(3):e12 [FREE Full text] [CrossRef] [Medline]
    68. Saslow LR, Kim S, Daubenmier JJ, Moskowitz JT, Phinney SD, Goldman V, et al. A randomized pilot trial of a moderate carbohydrate diet compared to a very low carbohydrate diet in overweight or obese individuals with type 2 diabetes mellitus or prediabetes. PLoS One 2014 Apr 09;9(4):e91027 [FREE Full text] [CrossRef] [Medline]
    69. Athinarayanan SJ, Adams RN, Hallberg SJ, McKenzie AL, Bhanpuri NH, Campbell WW, et al. Long-term effects of a novel continuous remote care intervention including nutritional ketosis for the management of type 2 diabetes: a 2-year non-randomized clinical trial. Front Endocrinol (Lausanne) 2019 Jun 05;10:348 [FREE Full text] [CrossRef] [Medline]
    70. Unwin D, Khalid AA, Unwin J, Crocombe D, Delon C, Martyn K, et al. Insights from a general practice service evaluation supporting a lower carbohydrate diet in patients with type 2 diabetes mellitus and prediabetes: a secondary analysis of routine clinic data including HbA1c, weight and prescribing over 6 years. BMJ Nutr Prev Health 2020 Dec;3(2):285-294 [FREE Full text] [CrossRef] [Medline]
    71. Adams RN, Athinarayanan SJ, McKenzie AL, Hallberg SJ, McCarter JP, Phinney SD, et al. Depressive symptoms improve over 2 years of type 2 diabetes treatment via a digital continuous remote care intervention focused on carbohydrate restriction. J Behav Med 2022 Jun;45(3):416-427 [FREE Full text] [CrossRef] [Medline]

    ‎
    HbA1c: hemoglobin A1c
    PHQ-8: 8-item Patient Health Questionnaire
    T2D: type 2 diabetes
    VLC: very low–carbohydrate

    Edited by L Quinlan; submitted 15.11.22; peer-reviewed by K Mokgalaboni, J Paul, C Robert; comments to author 14.01.23; revised version received 09.03.23; accepted 03.04.23; published 11.05.23

    Copyright

    ©Laura R Saslow, Amanda L Missel, Alison O’Brien, Sarah Kim, Frederick M Hecht, Judith T Moskowitz, Hovig Bayandorian, Martha Pietrucha, Kate Raymond, Blair Richards, Bradley Liestenfeltz, Ashley E Mason, Jennifer Daubenmier, James E Aikens. Originally published in JMIR Diabetes (https://diabetes.jmir.org), 11.05.2023.

    This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Diabetes, is properly cited. The complete bibliographic information, a link to the original publication on https://diabetes.jmir.org/, as well as this copyright and license information must be included.